On the other hand, T1AM injection stimulates hyperglycemia [156] and increases plasma glucagon levels in mice, but these effects seem to be rather dependent on the Gi/o coupled Alpha-2A adrenergic receptor (ADRA2A) than TAAR1, which is coupled with coupled Gs [157]. This evidence concerns the gene ADRA2A and Hyperglycemia.